Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age

NCT00346164 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00346164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00346164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
February 5, 2007
Completion date
March 31, 2022
Enrollment
588 (actual)
Sites
187

Conditions

As the registry lists them; a condition with its own page is linked.

adult alveolar soft-part sarcoma, adult angiosarcoma, adult epithelioid sarcoma, adult extraskeletal chondrosarcoma, adult extraskeletal osteosarcoma, adult fibrosarcoma, adult leiomyosarcoma, adult liposarcoma, adult malignant fibrous histiocytoma, adult malignant hemangiopericytoma, adult malignant mesenchymoma, adult neurofibrosarcoma, adult synovial sarcoma, childhood alveolar soft-part sarcoma, childhood angiosarcoma, childhood epithelioid sarcoma, childhood fibrosarcoma, childhood leiomyosarcoma, childhood liposarcoma, childhood malignant mesenchymoma, childhood neurofibrosarcoma, childhood synovial sarcoma, dermatofibrosarcoma protuberans, metastatic childhood soft tissue sarcoma, nonmetastatic childhood soft tissue sarcoma, stage i adult soft tissue sarcoma, stage ii adult soft tissue sarcoma, stage iii adult soft tissue sarcoma, stage iv adult soft tissue sarcoma